Skip to content
Tirzepatide Report
Provider review

Cabana Tirzepatide Review: Included Care and Refund Terms

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Cabana offers a named tirzepatide injection program through an online care platform. Its public pages describe clinical review, prescription fulfillment and follow-up, while the weight-loss category displays a $249 monthly starting headline. The reviewed tirzepatide page does not establish that $249 buys a specified tirzepatide dose and supply.12

That price-assignment gap matters: a category headline is not automatically the price of every medication in the category. Cabana's prescription final-sale policy is also material for anyone comparing a recurring package with flexible, individually purchased care.3 This review uses published information, without enrollment, a purchase or firsthand treatment.

Compare the complete offer

Published informationWhat to confirm
Tirzepatide injection is namedDose, quantity and medication price
Category headline: from $249/monthWhether it applies to your tirzepatide plan
Monthly renewal and portal cancellationProcessing cutoff for the next charge
Prescription sales are finalError handling and medical-denial terms
Public information checked October 2026. Individual access depends on clinical review and the selected plan.

A specific medication pathway

The dedicated product page names tirzepatide injection and describes consultation-based treatment. The product FAQs also discuss the clinician reviewing previous treatment before a possible switch from another GLP-1 medicine.14

This is stronger evidence of a current offer than a blog mentioning tirzepatide. It still does not establish that everyone who starts an intake will be prescribed it. The clinician must assess the history, current medicines and treatment goals. A consumer should compare the actual clinical process, including the availability of follow-up if the initial plan needs adjustment.

The page's modern wellness presentation is a branding choice. It does not independently validate pharmacy quality, clinical superiority or the results of a particular compounded preparation. Those questions require different evidence from the existence of a polished storefront.

What can be said about the price

The category page shows a starting figure of $249 per month and describes personalized concierge care. It also says subscription treatment renews monthly, with cancellation through the patient portal or support. The retrieved dedicated tirzepatide page did not connect that starting figure to a complete prescription quote.12

Ask for the total cost for the clinician's recommended treatment, rather than selecting a number from a category page. The written offer should identify the medication, formulation, milligrams, quantity, days supplied and renewal amount. Check whether the package includes supplies, shipping, follow-up and any required tests.

If a quote uses several months of medication or an introductory discount, ask what is paid upfront and what changes on renewal. The price of a consultation, the price of a compound and an all-inclusive recurring package can describe different purchases. A useful comparison keeps those boundaries visible.

Who prescribes and who dispenses?

Cabana's terms identify Cabana LLC and describe consultative services through affiliated healthcare providers. The pharmacy section describes selecting Cabana LLC or a partner in the Cabana Pharmacy Network for prescription shipment.5

That network language does not identify the actual dispenser assigned to a particular order. Before medication is supplied, obtain the clinical practice and pharmacy legal names, contact details and authorization for your state. Ask who handles a clinical concern after the initial prescription and who handles an order or shipping problem.

The terms also describe packaging restrictions for the pharmacy network, including medication not arriving in child-resistant packaging. That is a practical storage consideration if children or other household members could access the delivery. Confirm the packaging and follow the product's storage instructions.5

State access is conditional

The terms require adulthood and residence in a state where the relevant services operate. They say some services are available only in certain states. We did not establish a definitive current nationwide tirzepatide eligibility list from the inspected pages.5

Check your state before paying and confirm that the planned medication can be prescribed and dispensed there. Also ask whether a live visit is required. A provider operating in several states does not mean every product or service is available in all of them, and clinical eligibility is separate from geographic eligibility.

Cancellation is different from a refund

The weight-loss page describes monthly automatic renewal and cancel-anytime access through the portal or support. Cabana's refund policy says prescription-product sales are final and medications cannot be returned for reuse or resale. It invites contact about prescription-filling errors.23

Do not assume that stopping a subscription refunds a medication order already filled. Get the processing deadline for avoiding the next charge and ask what happens if a clinician declines the proposed treatment after payment. The reviewed policy does not support inventing an unconditional money-back promise.

For a shipment error, retain the packaging and order information and contact the relevant support channel promptly. A replacement or correction process can differ from an ordinary cancellation. Save the selected plan's checkout terms so that the actual purchase is clear if a dispute arises.

Before paying

Get these answers in writing

  • Ask for the numerical tirzepatide quote, not the category headline.
  • Identify the pharmacy and confirm state access.
  • Confirm cancellation before the next order is processed.

Compounded care needs its own evidence

Cabana's public product and FAQ material includes compounding disclosures and differentiates FDA-approved medicines from compounded preparations. FDA states compounded GLP-1 drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness or quality.146

Ask which formulation the proposed prescription uses. A reference to a trial of approved tirzepatide does not establish the results of a particular pharmacy-made product. Nor does a pharmacy-grade or physician-reviewed description establish patient-specific safety or an independent inspection finding.

Our assessment

Cabana supplies a specific tirzepatide pathway, meaningful care descriptions and a prescription refund policy. Its most important unresolved details are the actual dose-specific price, assigned dispenser and state access. Those are reasons to obtain the complete offer before buying rather than reasons to assign a fabricated price or a blanket business-quality judgment.

Compare the final package with other provider programs and the total care-options guide. Include approved Zepbound costs when discussing alternatives with your clinician.

To compare how to identify medication costs and clinical responsibilities before paying, see TideMedix and Evergreen.

Frequently asked questions

Is Cabana tirzepatide $249/month?

The weight-loss category advertises that starting amount, but the inspected tirzepatide page did not establish a complete dose-and-supply quote at that price.

Does Cabana accept prescription returns?

Its policy says prescription products cannot be returned for reuse or resale and sales are final. Contact support about filling errors; canceling future renewals is a separate process.

Is Cabana available in every state?

The terms limit services to states where they operate. Individual state and medication availability must be confirmed.

References(6)

  1. Cabana (2026). Tirzepatide injection. Cabana.
  2. Cabana (2026). Weight-loss category. Cabana.
  3. Cabana (2026). Refund policy. Cabana.
  4. Cabana (2026). Product FAQs. Cabana.
  5. Cabana (2026). Terms and Conditions. Cabana.
  6. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. Read source

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.